Synthesis of 1,2,4-Oxadiazin-5(6<i>H</i>)-One Derivatives and Their Biological Investigation as Monoamine Oxidase Inhibitors
Monoamine oxidase (MAO) plays a key role in the pathogenesis of central nervous system disorders, and MAO inhibitors have been used in the treatment of depression and Parkinson’s disease. In the search for new classes of MAO inhibitors, the present study investigated a series of 1,2,4-oxadiazin-5(6&...
Saved in:
| Main Authors: | Sofia I. Presnukhina, Valentina D. Kotlyarova, Anton A. Shetnev, Sergey V. Baykov, Rakhymzhan Turmanov, Nurbol Appazov, Rakhmetulla Zhapparbergenov, Leilya Zhussupova, Nurila Togyzbayeva, Stephanus J. Cloete, Mikhail K. Korsakov, Vadim P. Boyarskiy, Anél Petzer, Jacobus P. Petzer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/29/23/5550 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diastereoselective Synthesis and Biological Evaluation of Spiro[chromane-2,4′-pyrimidin]-2′(3′<i>H</i>)-ones as Novel Antimicrobial and Antioxidant Agents
by: Alena S. Karandeeva, et al.
Published: (2025-07-01) -
Helping other customers to avoid harmful brands: The role of idealism, attitude and cynicism
by: Estelle van Tonder, et al.
Published: (2024-11-01) -
Synthesis of New Chiral and Nonchiral Pyrido [3,2-e],[1,3,4] oxadiazine Derivatives
by: L. S. Shet, et al.
Published: (2010-01-01) -
Monoamine Reuptake Inhibitors in Parkinson’s Disease
by: Philippe Huot, et al.
Published: (2015-01-01) -
Synthesis of Some New 1,2,4-Triazine and 1,2,5-Oxadiazine Derivatives with Antimicrobial Activity
by: Heba E. Hashem, et al.
Published: (2019-01-01)